For years, many healthcare executives treated claim denials as a back-office irritation—a revenue problem to be delegated, ...
The Reuters tech team gathered this week for our year-end brainstorm — a chance to step back and look at what surprised us ...
It was the first time in nearly a year that hearings in the case had been convened, with a new judge presiding. Khalid Shaikh ...
Cybersecurity principles are simple, says Databricks' Field CISO. The hard part is doing them at scale across thousands of users and hundreds of applications. The company thinks its data platform – ...
Each year, globally, poor software quality costs businesses over $2.41 trillion, creating an accumulated technical debt of $1 ...
Judge Pauline Newman has served with distinction on the U.S. Court of Appeals for the Federal Circuit since her appointment ...
The Avid Outdoorsman on MSN
November gun background checks fell — what the data shows
Gun background checks in November slipped noticeably, interrupting the long run of elevated demand that has defined recent ...
VanEck Pharmaceutical ETF is rated a Buy with stability, earnings visibility, and resilience across volatile market cycles.
Cannabis is entering a phase where identity matters more than narrative. As federal oversight takes shape, the industry is being pulled out of a patchwork of state systems and into a framework that ...
Palantir posts 62.8% YoY revenue growth, expanding margins, and US commercial sales up 121%, showing B2B shift and AI peer strength. See why PLTR stock is a buy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results